First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
Clinical trial NCT05103046 · UNKNOWN
Trial details
- NCT number
- NCT05103046
- Sponsor
- 1200 Pharma, LLC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-23
- Primary completion
- 2024-12-15
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.